Target intelligence / Profile preview

Glycoprotein D of herpes simplex virus (gD)

Target
gD
Molecular classification
Viral envelope glycoprotein, Receptor-binding protein, Other
01

Overview

Glycoprotein D (gD) is an essential envelope glycoprotein present on the surface of herpes simplex virus (HSV) types 1 and 2, required for viral infectivity and entry into host cells[1][6][7]. gD acts by binding to multiple host cell receptors including nectin-1, herpesvirus entry mediator (HVEM, TNFRSF14), and 3-O-sulfated heparan sulfate, thereby determining the tropism of HSV and facilitating viral fusion with the cell membrane[2][3][4][7]. Binding of gD to a cellular receptor triggers conformational changes that activate other viral glycoproteins (gH/gL and gB), resulting in fusion of the viral and cellular membranes for virus entry[3][4][5]. gD is also a major antigenic target in vaccine development against HSV and in diagnostic assays; neutralizing antibodies against gD can block viral entry and fusion, representing an important antiviral strategy[5]. Structural studies indicate that gD consists of regions responsible for receptor binding and fusion activation, with antigenic and structural differences between HSV-1 and HSV-2 gD variants[1][6].

Other names
Glycoprotein DgDHSV-1 gDHSV-2 gDEnvelope glycoprotein D
02

Mechanism of action

Blocking gD-receptor interactions to prevent virus entry Neutralizing antibody binding to gD to inhibit infection/fusion

03

Biological functions

Virus entryReceptor bindingActivation of viral fusion machineryCell-to-cell spread
04

Disease associations

Infection (herpes simplex virus infection)
05

Safety considerations

Immunogenicity (antibody-dependent enhancement is possible)Potential for viral escape mutationsChallenges in designing broadly protective vaccines
06

Interacting drugs

No approved drugs directly targeting gD, but gD is a key target for vaccine development and antibody therapies
07

Biomarkers

Antibody response to gD in HSV infection or vaccine trials

Beyond the preview

Go deeper on Glycoprotein D of herpes simplex virus (gD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycoprotein D of herpes simplex virus (gD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call